Brokerages forecast that HMS Holdings Corp (NASDAQ:HMSY) will report $143.71 million in sales for the current fiscal quarter, Zacks reports. Six analysts have provided estimates for HMS’s earnings, with the lowest sales estimate coming in at $142.60 million and the highest estimate coming in at $145.10 million. HMS posted sales of $141.43 million in the same quarter last year, which indicates a positive year over year growth rate of 1.6%. The company is expected to announce its next quarterly earnings results before the market opens on Friday, May 3rd.
On average, analysts expect that HMS will report full-year sales of $647.64 million for the current fiscal year, with estimates ranging from $641.40 million to $658.00 million. For the next fiscal year, analysts anticipate that the firm will report sales of $701.83 million, with estimates ranging from $685.90 million to $741.00 million. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that cover HMS.
HMS (NASDAQ:HMSY) last issued its earnings results on Friday, February 22nd. The business services provider reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.03. The business had revenue of $155.80 million during the quarter, compared to analyst estimates of $155.84 million. HMS had a return on equity of 14.21% and a net margin of 9.19%. HMS’s revenue was up 4.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.24 earnings per share.
Shares of HMSY stock traded up $0.47 during trading hours on Tuesday, hitting $28.11. 682,959 shares of the company’s stock were exchanged, compared to its average volume of 530,245. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.40 and a current ratio of 4.40. The stock has a market capitalization of $2.45 billion, a PE ratio of 33.46, a PEG ratio of 2.64 and a beta of 1.61. HMS has a 52 week low of $17.11 and a 52 week high of $38.15.
In other news, insider Meredith W. Bjorck sold 2,362 shares of HMS stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $30.10, for a total transaction of $71,096.20. Following the completion of the transaction, the insider now directly owns 51,755 shares in the company, valued at approximately $1,557,825.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William F. Miller III sold 16,953 shares of HMS stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $32.50, for a total value of $550,972.50. Following the transaction, the director now owns 157,418 shares of the company’s stock, valued at $5,116,085. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,018,795 shares of company stock worth $35,023,853. 2.87% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently modified their holdings of HMSY. FMR LLC bought a new position in shares of HMS during the 3rd quarter worth approximately $27,949,000. Franklin Resources Inc. bought a new position in shares of HMS during the 3rd quarter worth approximately $295,000. Allianz Asset Management GmbH lifted its holdings in HMS by 22.1% during the 3rd quarter. Allianz Asset Management GmbH now owns 95,860 shares of the business services provider’s stock worth $3,146,000 after purchasing an additional 17,380 shares during the last quarter. Riverhead Capital Management LLC lifted its holdings in HMS by 19.2% during the 3rd quarter. Riverhead Capital Management LLC now owns 9,320 shares of the business services provider’s stock worth $306,000 after purchasing an additional 1,500 shares during the last quarter. Finally, BlueMountain Capital Management LLC acquired a new stake in HMS during the 3rd quarter worth approximately $146,000. Institutional investors own 95.47% of the company’s stock.
HMS Company Profile
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. The company offers coordination of benefits services to government and commercial healthcare payers to ensure that the correct party pays the claim; and population management solutions that provide risk-bearing organizations with intelligence across their member populations to identify risks, and enhance patient engagement and outcomes, as well as payment integrity, care management and consumer engagement, and analytical solutions.
Recommended Story: What are retained earnings?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.